FDA Approved Drug with New Mechanism of Action for Treatment of Schizophrenia
On Sept. 26, 2024, the U.S. Food and Drug Administration (FDA) approved Bristol-Myers Squibb’s Cobenfy (xanomeline and trospium…
FDA approved Risperidone for use as atypical antipsychotic medication
On Dec. 29, 1993, the U.S. Food and Drug Administration (FDA) approved indications for oral risperidone (tablets, oral…
The first edition of “Diagnostic and Statistical Manual of Mental Disorders” mentioned autism to describe symptoms of schizophrenia before puberty
In 1952, the first edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM) was published and…